ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05217	Basal cell carcinoma	18/173	68/7206	1.29977827673e-14
ko04360	Axon guidance	28/173	233/7206	9.19147747131e-13
ko05200	Pathways in cancer	40/173	492/7206	3.1787213051e-12
ko05224	Breast cancer	23/173	174/7206	1.6711307358e-11
ko04390	Hippo signaling pathway	23/173	188/7206	8.36754560424e-11
ko04550	Signaling pathways regulating pluripotency of stem cells	21/173	165/7206	2.8092717597e-10
ko04310	Wnt signaling pathway	19/173	181/7206	5.2677534864e-08
ko04330	Notch signaling pathway	10/173	62/7206	1.79241027198e-06
ko04916	Melanogenesis	14/173	142/7206	6.90243580731e-06
ko05166	HTLV-I infection	20/173	292/7206	2.04086367387e-05
ko05206	MicroRNAs in cancer	15/173	177/7206	2.0412353295e-05
ko05205	Proteoglycans in cancer	19/173	271/7206	2.40793673292e-05
ko04110	Cell cycle	13/173	145/7206	4.11594176233e-05
ko04340	Hedgehog signaling pathway	8/173	58/7206	6.46256202622e-05
ko04151	PI3K-Akt signaling pathway	22/173	390/7206	0.000206444738749
ko05222	Small cell lung cancer	9/173	89/7206	0.000262895115916
ko04391	Hippo signaling pathway - fly	9/173	90/7206	0.00028617231764
ko01522	Endocrine resistance	10/173	124/7206	0.000755020106723
ko04150	mTOR signaling pathway	12/173	184/7206	0.00151634887094
ko04658	Th1 and Th2 cell differentiation	8/173	96/7206	0.00206404734175
ko04919	Thyroid hormone signaling pathway	10/173	143/7206	0.00223545414844
ko04350	TGF-beta signaling pathway	8/173	103/7206	0.00321222501426
ko05215	Prostate cancer	8/173	111/7206	0.00507529141224
ko04392	Hippo signaling pathway -multiple species	4/173	31/7206	0.00608546153498
ko04015	Rap1 signaling pathway	14/173	278/7206	0.00785174160622
ko04512	ECM-receptor interaction	6/173	79/7206	0.0114907921006
ko04520	Adherens junction	7/173	103/7206	0.011686809691
ko05230	Central carbon metabolism in cancer	6/173	81/7206	0.0129025205314
ko05220	Chronic myeloid leukemia	6/173	85/7206	0.0160831984947
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	3/173	26/7206	0.0235766730217
ko04024	cAMP signaling pathway	13/173	279/7206	0.0245800401421
ko04014	Ras signaling pathway	13/173	279/7206	0.0245800401421
ko01523	Antifolate resistance	3/173	30/7206	0.0343475401272
ko05161	Hepatitis B	9/173	173/7206	0.0373440527178
ko04011	MAPK signaling pathway - yeast	4/173	53/7206	0.0377723041613
ko05212	Pancreatic cancer	5/173	83/7206	0.0487814024131